{"content":"<li class=\"n-box-item date-title\" data-end=\"1518670799\" data-start=\"1518584400\" data-txt=\"Monday, December 23, 2019\">Wednesday, February 14, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3331261\" data-ts=\"1518659891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KGC\" target=\"_blank\">KGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331261-kinross-goldminus-6-after-q4-miss-guides-2018-production-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinross Gold -6% after Q4 miss; guides 2018 production lower</a></h4><ul>     <li>Kinross Gold (NYSE:<a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a>) <font color='red'>-5.8%</font> after-hours as it misses <a href=\"https://seekingalpha.com/news/3331218-kinross-gold-misses-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a> expectations with a 10% Y/Y decline in revenues.</li>     <li>KGC says Q4 production totaled 652.7K gold equiv. oz., -12.5% Y/Y, at all-in sustaining cost of $1,019/oz,, nearly unchanged compared to the year-ago quarter; for FY 2017, production was 2.67M gold equiv. oz., -4% Y/Y, with AISC of $954/oz. vs. $984/oz. for FY 2016.</li>     <li>For 2018, KGC expects to produce ~2.5M gold equiv. oz. at all-in sustaining cost of $975/oz., with total capex forecast at $1.075B.</li>     <li>Separately, KGC <a href=\"https://seekingalpha.com/pr/17075355-kinross-announces-acquisition-power-plants-brazil-secure-long-term-low-cost-power-paracatu\" target=\"_blank\">agrees to acquire</a> two hydroelectric power plants in Brazil from Gerdau (NYSE:<a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a>) for $257M to secure a long-term supply of power for its Paracatu mine.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331261\" data-linked=\"Kinross Gold -6% after Q4 miss; guides 2018 production lower\" data-tweet=\"$KGC $KGC $GGB - Kinross Gold -6% after Q4 miss; guides 2018 production lower https://seekingalpha.com/news/3331261-kinross-goldminus-6-after-q4-miss-guides-2018-production-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3331261-kinross-goldminus-6-after-q4-miss-guides-2018-production-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331257\" data-ts=\"1518655599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331257-netflix-poaches-top-fox-tv-creator-murphy-in-five-year-megadeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix poaches top Fox TV creator Murphy in five-year megadeal</a></h4><ul>     <li>Seemingly concerned about what's next for media assets at Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) that are headed into the umbrella of Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>), Ryan Murphy -- TV's most prolific producer -- has signed a deal said to be <a href=\"http://variety.com/2018/tv/news/ryan-murphy-netflix-deal-fox-fx-1202699152/\" target=\"_blank\">worth a hefty $250M-$300M over five years</a> with Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>).</li>     <li>Murphy has been responsible for such Fox/FX hits as <i>Nip/Tuck, Glee, American Horror Story</i> and <i>American Crime Story</i> over the past 15 years.</li>     <li>The total value of the deal depends on viewership targets.</li>     <li>The change is unquestionably a blow for Fox, which has four Murphy shows on FX right now (and <i>American Horror Story</i> is FX's top-rated series).</li>     <li>It's Netflix's second big deal with one of TV's biggest hitmakers: Last August, it <a href=\"https://seekingalpha.com/news/3288826-netflix-poaches-hitmaking-producer-rhimes-abc\" target=\"_blank\">poached Shonda Rhimes from ABC</a> with a five-year deal for at least $100M.</li>     <li>Netflix shares <font color='green'>gained 3%</font> today, while Fox was mostly flat and Disney closed <font color='green'>up 0.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331257\" data-linked=\"Netflix poaches top Fox TV creator Murphy in five-year megadeal\" data-tweet=\"$FOX $FOX $FOXA - Netflix poaches top Fox TV creator Murphy in five-year megadeal https://seekingalpha.com/news/3331257-netflix-poaches-top-fox-tv-creator-murphy-in-five-year-megadeal?source=tweet\" data-url=\"https://seekingalpha.com/news/3331257-netflix-poaches-top-fox-tv-creator-murphy-in-five-year-megadeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331255\" data-ts=\"1518653861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQIX\" target=\"_blank\">EQIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331255-equinixminus-3_9-amid-falling-q4-ffo-infomart-dallas-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinix -3.9% amid falling Q4 FFO, Infomart Dallas deal</a></h4><ul>   <li>Equinix (NASDAQ:<a href='https://seekingalpha.com/symbol/EQIX' title='Equinix, Inc.'>EQIX</a>) is <font color='red'>3.9% lower</font> after hours after its <a href=\"https://seekingalpha.com/news/3331119-equinix-eps-0_82\" target=\"_blank\">Q4 report</a>, marked by a drop in FFO and a major deal for a giant information hub.</li>    <li>Funds from operations fell to $285.6M from $286.1M; adjusted funds from operations dropped to $381.5M from $391.3M.</li>    <li>Adjusted EBITDA rose to $564.8M from $550.3M, but missed an expected $569.9M.</li>    <li>The company is <a href=\"https://seekingalpha.com/pr/17075181-equinix-acquire-infomart-dallas-800-million-deal\" target=\"_blank\">buying Infomart Dallas</a> -- one of the biggest interconnection hubs in the country -- in a deal valued at $800M from ASB Real Estate Investments. Equinix has four of its eight Dallas-area IBX centers at Infomart.</li>    <li>For Q1, it's guiding to revenues of $1.204B-$1.212B (below consensus for $1.223B) and EBITDA of $549M-$557M (light of consensus for $578.8M). For the full year, it's forecasting adjusted funds from operations of $1.635B (14% gain Y/Y), revenues of more than $5.01B (consensus is for $5.08B), a 15% Y/Y gain, and EBITDA exceeding $2.385B (vs. consensus for $2.45B).</li>    <li><a href=\"https://seekingalpha.com/pr/17075166-equinix-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331255\" data-linked=\"Equinix -3.9% amid falling Q4 FFO, Infomart Dallas deal\" data-tweet=\"$EQIX - Equinix -3.9% amid falling Q4 FFO, Infomart Dallas deal https://seekingalpha.com/news/3331255-equinixminus-3_9-amid-falling-q4-ffo-infomart-dallas-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3331255-equinixminus-3_9-amid-falling-q4-ffo-infomart-dallas-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331253\" data-ts=\"1518651814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CF\" target=\"_blank\">CF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331253-cf-industriesplus-2-following-lighter-expected-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CF Industries +2% following lighter than expected Q4 loss</a></h4><ul>     <li>CF&nbsp;Industries (NYSE:<a href='https://seekingalpha.com/symbol/CF' title='CF Industries Holdings, Inc.'>CF</a>) <font color='green'>+2.2%</font> after-hours as it reports a smaller than expected <a href=\"https://seekingalpha.com/news/3331177-cf-industries-beats-0_06-beats-revenue\" target=\"_blank\">Q4 loss</a> and a 27% Y/Y increase in revenues to a higher than anticipated $1.1B, amid higher sales volumes across most segments and higher average selling  prices across all segments.</li>     <li>CF says Q4 total sales volume of 5.3M tons was the highest quarterly sales volume in the company's history, beating the previous record by 5%; CF cites increased production increased at the Donaldsonville and Port Neal Nitrogen Complex.</li>     <li>Average selling prices for the quarter were higher Y/Y across all segments due largely to a tighter global nitrogen supply and demand balance; the company's average selling price for ammonia was $285/ton in Q4 vs. $277 in the year-earlier quarter, the average selling price for urea was $244/ton vs. $214 a year ago, and the average selling price for UAN was $150/ton vs. $149 a year ago.</li>     <li>CF expects H1 nitrogen prices to be supported above year-ago prices by the combination of a somewhat weaker U.S. dollar, higher energy costs in key producing regions, reduced production in China, higher oil and freight costs, and steady global demand.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331253\" data-linked=\"CF Industries +2% following lighter than expected Q4 loss\" data-tweet=\"$CF - CF Industries +2% following lighter than expected Q4 loss https://seekingalpha.com/news/3331253-cf-industriesplus-2-following-lighter-expected-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3331253-cf-industriesplus-2-following-lighter-expected-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331251\" data-ts=\"1518650839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GG\" target=\"_blank\">GG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331251-goldcorpplus-3-q4-net-profit-doubles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldcorp +3% as Q4 net profit more than doubles</a></h4><ul>     <li>Goldcorp (NYSE:<a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a>)&nbsp;<font color='green'>+3.2%</font> after-hours as <a href=\"https://seekingalpha.com/news/3331200-goldcorp-beats-0_17-misses-revenue\" target=\"_blank\">Q4 earnings</a> more than double from a year ago and easily beats analyst expectations, and its program to implement $250M of sustainable annual efficiencies by mid-2018 is on track with nearly $200M achieved in 2017 across the company's portfolio.</li>     <li>GG says Q4 gold production of 646K oz. fell 15% Y/Y but full-year gold output of 2.57M oz. edged past the midpoint of company guidance of 2.5M oz.; Q4 all-in sustaining costs of $870/oz. exceeded AISC of $747/oz. for the year-ago quarter while full-year AISC of $824/oz. was in line with improved midpoint guidance of $825/oz., which the company says reflects progress in its sustainable efficiency program.</li>     <li>GG expects to produce 2.5M oz. of gold in 2018, in line with previous guidance, with AISC seen declining  further to ~$800/oz.; over the longer term, the company forecasts gold production to rise 20% to 3M oz. by 2021 with AISC declining 20% to ~$700/oz.over the same period.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331251\" data-linked=\"Goldcorp +3% as Q4 net profit more than doubles\" data-tweet=\"$GG - Goldcorp +3% as Q4 net profit more than doubles https://seekingalpha.com/news/3331251-goldcorpplus-3-q4-net-profit-doubles?source=tweet\" data-url=\"https://seekingalpha.com/news/3331251-goldcorpplus-3-q4-net-profit-doubles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331086\" data-ts=\"1518649740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXW\" target=\"_blank\">CXW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331086-corecivic-in-expansion-mode-developing-new-facility-in-kansas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corecivic in expansion mode, developing a new facility in Kansas</a></h4><ul><li>Corecivic (NYSE:<a href='https://seekingalpha.com/symbol/CXW' title='CoreCivic, Inc.'>CXW</a>)&nbsp;reported Q4 FFO of $0.60 per share, vs&nbsp;consensus of $0.55 per share. Revenues fell 5.1% Y/Y to $440.6M vs $429.8M consensus.</li><li>The company issued&nbsp;guidance&nbsp;for FY 2018 seeing FFO/share of $2.23 to 2.31.</li><li>CoreCivic entered into new contracts with three different states and in 2018, the REIT was awarded a contract to develop a new correctional facility in a public-private partnership that will be leased and operated by a government agency in Lansing, Kan.</li><li>Conference call at 11 a.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331147-corecivic-beats-0_05-beats-revenue\" target=\"_blank\">Corecivic beats by $0.05, beats on revenue</a> (Feb. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331086\" data-linked=\"Corecivic in expansion mode, developing a new facility in Kansas\" data-tweet=\"$CXW - Corecivic in expansion mode, developing a new facility in Kansas https://seekingalpha.com/news/3331086-corecivic-in-expansion-mode-developing-new-facility-in-kansas?source=tweet\" data-url=\"https://seekingalpha.com/news/3331086-corecivic-in-expansion-mode-developing-new-facility-in-kansas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331247\" data-ts=\"1518649072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRO\" target=\"_blank\">MRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331247-marathon-oil-moves-higher-after-q4-earnings-revenues-top-forecasts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Oil moves higher after Q4 earnings, revenues top forecasts</a></h4><ul>     <li>Marathon Oil (NYSE:<a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a>) <font color='green'>+1.5%</font> after-hours as it reports better than expected <a href=\"https://www.reuters.com/article/us-marathn-oil-results/marathon-oil-profit-beats-forecasts-on-rising-crude-cost-cuts-idUSKCN1FY345\" target=\"_blank\">Q4 earnings</a> and a 23% Y/Y revenue increase to $1.38B, also more than anticipated.</li>     <li>MRO plans a 2018 capital budget of $2.3B, up slightly vs. $2.2B in 2017, with ~60% to be spent in the Bakken shale and Eagle Ford shale and the remainder in the Permian Basin and in Oklahoma; the company says the budget should maintain breakeven at $50/bbl oil.</li>     <li>Q4 production rose 4% Q/Q to 383K boe/day, with U.S. resource play production climbing 10% Q/Q to average 249K net boe/day.</li>     <li>MRO forecasts total 2018 production available for sale will average 390K-410K net boe/day, up 12% Y/Y at the midpoint; annual oil output available for sale is seen increasing 18% at the midpoint, driven by 20%-25% oil growth in the U.S. resource plays.</li>     <li>MRO expects Q1 U.S. production will average 265K-275K net boe/day, while international output, excluding Libya, averages 105K-115K net boe/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331247\" data-linked=\"Marathon Oil moves higher after Q4 earnings, revenues top forecasts\" data-tweet=\"$MRO - Marathon Oil moves higher after Q4 earnings, revenues top forecasts https://seekingalpha.com/news/3331247-marathon-oil-moves-higher-after-q4-earnings-revenues-top-forecasts?source=tweet\" data-url=\"https://seekingalpha.com/news/3331247-marathon-oil-moves-higher-after-q4-earnings-revenues-top-forecasts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331077\" data-ts=\"1518648035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARR\" target=\"_blank\">ARR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331077-armour-residential-tops-q4-estimates-reports-big-drop-in-book-value-for-q1-sharesminus-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Armour Residential tops Q4 estimates, reports big drop in book value for Q1; shares -1.5%</a></h4><ul>     <li>Q4 core income of $32.5M or $0.68 per share vs. $32.6M and $0.69 earned in Q3. Dividend run rate is $0.57 per quarter.</li><li>Dec. 31 book value per share of $26.62 was down $0.06 from three months earlier.</li><li>Economic return on book value for the quarter was 1.9%.</li><li>Updating for goings-on thus far in Q1, the company says book value has dropped to $24.72 as of Feb. 13. The current price of $22.41 is a 9.3% discount to book.</li><li>The <a href=\"https://www.webcaster4.com/Webcast/Page/896/23198\" target=\"_blank\">conference call</a> is just underway.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331163-armour-residential-reit-beats-0_02\" target=\"_blank\">ARMOUR Residential REIT beats by $0.02</a> (Feb. 14)</li><li><a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a>&nbsp;<font color='red'>-1.5%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331077\" data-linked=\"Armour Residential tops Q4 estimates, reports big drop in book value for Q1; shares -1.5%\" data-tweet=\"$ARR - Armour Residential tops Q4 estimates, reports big drop in book value for Q1; shares -1.5% https://seekingalpha.com/news/3331077-armour-residential-tops-q4-estimates-reports-big-drop-in-book-value-for-q1-sharesminus-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3331077-armour-residential-tops-q4-estimates-reports-big-drop-in-book-value-for-q1-sharesminus-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331236\" data-ts=\"1518647721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XEC\" target=\"_blank\">XEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331236-cimarex-energyminus-3-2018-capex-projected-rising-29-to-1_65b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cimarex Energy -3% as 2018 capex projected rising 29% to ~$1.65B</a></h4><ul>     <li>Cimarex Energy (NYSE:<a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a>) <font color='red'>-3.1%</font> after-hours despite reporting better than expected <a href=\"https://seekingalpha.com/news/3331186-cimarex-energy-beats-0_07-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, as the company projects 2018 capex of $1.6B-$1.7B, a 29% increase from 2017 levels at the midpoint.</li>     <li>Q4 production averaged 1.2B cfe/day, with oil production rising 36% Y/Y; proved reserves increased 16% to 3.4T cfe while replacing 211% of 2017 production.</li>     <li>XEC expects Q1 production will average 198K-207K boe/day, with oil production increasing ~3% Q/Q while natural gas and natural gas liquids come in flat.</li>     <li>For FY 2018, XEC forecasts production of 211K-221K boe/day, up 14% at the midpoint from 2017 levels, with oil production rising 21%-26%. Fourth quarter 2018 oil production is projected to  increase 29-34 percent over fourth quarter 2017 levels</li>     <li>XEC says it plans to invest $1.3B-$1.4B on the drilling and completion of 127 net wells during 2018, with nearly 70% of capital spent in the Permian region and the remainder in the Mid-Continent.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331236\" data-linked=\"Cimarex Energy -3% as 2018 capex projected rising 29% to ~$1.65B\" data-tweet=\"$XEC - Cimarex Energy -3% as 2018 capex projected rising 29% to ~$1.65B https://seekingalpha.com/news/3331236-cimarex-energyminus-3-2018-capex-projected-rising-29-to-1_65b?source=tweet\" data-url=\"https://seekingalpha.com/news/3331236-cimarex-energyminus-3-2018-capex-projected-rising-29-to-1_65b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331235\" data-ts=\"1518647698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331235-after-hours-gainers-losers-2-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (2/14/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a> <font color='green'>+16.8%</font>. <a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='green'>+14.5%</font>. <a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a> <font color='green'>+9.6%</font>. <a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+8.0%</font>. <a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='green'>+6.0%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a> <font color='red'>-8.6%</font>. <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='red'>-7.5%</font>. <a href='https://seekingalpha.com/symbol/CTAS' title='Cintas Corporation'>CTAS</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/EQIX' title='Equinix, Inc.'>EQIX</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/MAR' title='Marriott International, Inc.'>MAR</a> <font color='red'>-3.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331235\" data-linked=\"After Hours Gainers / Losers (2/14/2018)\" data-tweet=\"$TRIP $TRIP $SEDG - After Hours Gainers / Losers (2/14/2018) https://seekingalpha.com/news/3331235-after-hours-gainers-losers-2-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331235-after-hours-gainers-losers-2-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331225\" data-ts=\"1518646330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPI\" target=\"_blank\">LPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331225-laredo-petroleumplus-4-after-q4-beat-200m-stock-buyback-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Laredo Petroleum +4% after Q4 beat, $200M stock buyback program</a></h4><ul>     <li>Laredo Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/LPI' title='Laredo Petroleum Holdings, Inc.'>LPI</a>) <font color='green'>+4.6%</font> after-hours following a narrow <a href=\"https://seekingalpha.com/news/3331189-laredo-petroleum-beats-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat but also posting a 30% Y/Y revenue increase and announcing a $200M share repurchase program.</li>     <li>LPI reiterates its anticipated FY 2018 production growth guidance of at&nbsp;least 10% compared with 2017, and forecasts Q1 production averaging 62K boe/day.</li>     <li>\"During 2017, Laredo's development plan yielded well-level returns on invested capital exceeding 30% while making meaningful progress towards co-developing multiple landing points in our Upper and Middle Wolfcamp  formations,\" LPI says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331225\" data-linked=\"Laredo Petroleum +4% after Q4 beat, $200M stock buyback program\" data-tweet=\"$LPI - Laredo Petroleum +4% after Q4 beat, $200M stock buyback program https://seekingalpha.com/news/3331225-laredo-petroleumplus-4-after-q4-beat-200m-stock-buyback-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3331225-laredo-petroleumplus-4-after-q4-beat-200m-stock-buyback-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331223\" data-ts=\"1518646258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331223-centurylinkplus-11_2-after-level-3-boost-to-q4-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenturyLink +11.2% after Level 3 boost to Q4 earnings</a></h4><ul>   <li>CenturyLink (NYSE:<a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a>) is <font color='green'>up 11.2%</font> on after-hours volume of nearly 1M shares following <a href=\"https://seekingalpha.com/news/3331171-centurylink-eps-1_26\" target=\"_blank\">Q4 earnings</a> where a strong quarter for revenues gave a lift to wrap up the year.</li>    <li>Revenues grew 24% Y/Y to $5.323B, lifting the company to a 1% gain for the full year, boosted by very healthy results in a business segment that's added Level 3 Communications.</li>    <li>Results include two months of Level 3 performance. On a pro forma basis (assuming Level 3 acquisition and selling data centers/co-location had wrapped Jan. 1, 2016), revenue was flat at $6B, and EBITDA was flat on an adjusted and unadjusted basis, while capex dropped to $829M from $1.25B.</li>    <li>Revenue by segment: Business, $3.73B (up 42%); Consumer, $1.4B (down 5.7%).</li>    <li>Cash, equivalents and marketable securities were $551M as of Dec. 31.</li>    <li>For 2018, it's guiding to EBITDA of $8.75B-$8.95B (vs. consensus for $8.86B), free cash flow (before dividends) of $3.15B-$3.35B, and dividends of $2.3B, as well as capex about 16% of revenue and a full-year effective income tax rate of about 25%.</li>    <li><a href=\"https://seekingalpha.com/pr/17075288-centurylink-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331223\" data-linked=\"CenturyLink +11.2% after Level 3 boost to Q4 earnings\" data-tweet=\"$CTL - CenturyLink +11.2% after Level 3 boost to Q4 earnings https://seekingalpha.com/news/3331223-centurylinkplus-11_2-after-level-3-boost-to-q4-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3331223-centurylinkplus-11_2-after-level-3-boost-to-q4-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331213\" data-ts=\"1518645471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331213-avid-bio-readies-stock-offering-shares-down-15-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bio readies stock offering; shares down 15% after hours</a></h4><ul><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) <a href=\"https://seekingalpha.com/pr/17075176-avid-bioservices-announces-proposed-offering-common-stock\" target=\"_blank\">commences </a>a public offering of common stock. Price, volume and terms have yet to be announced. Shares are down&nbsp;<font color='red'>15%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331213\" data-linked=\"Avid Bio readies stock offering; shares down 15% after hours\" data-tweet=\"$CDMO - Avid Bio readies stock offering; shares down 15% after hours https://seekingalpha.com/news/3331213-avid-bio-readies-stock-offering-shares-down-15-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3331213-avid-bio-readies-stock-offering-shares-down-15-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331196\" data-ts=\"1518644789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/A\" target=\"_blank\">A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331196-agilent-fq1-top-line-up-14-non-gaap-earnings-up-26-cash-flow-up-85-guidance-raised-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agilent FQ1 top line up 14%; non-GAAP earnings up 26%; cash flow up 85%; guidance raised; shares up 2% after hours</a></h4><ul><li>Agilent (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies Inc.'>A</a>) <a href=\"https://seekingalpha.com/pr/17075194-agilent-technologies-reports-first-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">fiscal Q1 results</a> ($M): Revenues: 1,211 (+13.5%).</li><li>Net loss: (320) (-290.5%); non-GAAP net income: 216 (+25.6%); loss/share: (0.99) (-290.4%); non-GAAP EPS: 0.66 (+24.5%); cash flow ops: 215 (+85.3%).</li><li>GAAP results negatively impacted by a $533M charge related to U.S. tax reform.</li><li><strong>Fiscal 2018 guidance</strong>: Revenue growth: midpoint of 5.50% from midpoint of 4.25%; non-GAAP EPS: midpoint of $2.65 from midpoint of $2.53; cash flow ops: $1.05B from $970M.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331196\" data-linked=\"Agilent FQ1 top line up 14%; non-GAAP earnings up 26%; cash flow up 85%; guidance raised; shares up 2% after hours\" data-tweet=\"$A - Agilent FQ1 top line up 14%; non-GAAP earnings up 26%; cash flow up 85%; guidance raised; shares up 2% after hours https://seekingalpha.com/news/3331196-agilent-fq1-top-line-up-14-non-gaap-earnings-up-26-cash-flow-up-85-guidance-raised-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3331196-agilent-fq1-top-line-up-14-non-gaap-earnings-up-26-cash-flow-up-85-guidance-raised-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331187\" data-ts=\"1518644316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331187-netapp-slides-despite-delivering-beats-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetApp slides despite delivering beats in Q3</a></h4><ul>   <li>NetApp (NASDAQ:<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>) has <font color='red'>tumbled 8.6%</font> after hours on heavy volume despite <a href=\"https://seekingalpha.com/news/3331114-netapp-beats-0_08-beats-revenue\" target=\"_blank\">fiscal Q3 earnings</a> where it topped expectations with the help of double-digit gains in product sales.</li>    <li>Net income swung to a headline loss of $506M, but affected by tax reform legislation and the transition tax on foreign earnings. On a non-GAAP basis, net income rose to $273M from a year-ago $231M.</li>    <li>The company notes its $2B in all-flash array annunalized net revenue run rate was up nearly 50% Y/Y.</li>    <li>Revenue breakout: Product, $920M (up 17.3%); Software maintenance, $237M (down 1.3%); Hardware maintenance and other services, $366M (down 3.7%).</li>    <li>Cash, equivalents and investments were $5.6B at quarter's end; cash from operations was $420M vs. a year-ago $235M.</li>    <li>For Q4, it's guiding to net revenues of $1.525B-$1.675B (vs. consensus for $1.568B), and EPS of $0.95-$1.03 (vs. consensus for $1.00).</li>    <li><a href=\"http://investors.netapp.com/\" target=\"_blank\">Conference call</a> to come at 5:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17075173-netapp-reports-third-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331187\" data-linked=\"NetApp slides despite delivering beats in Q3\" data-tweet=\"$NTAP - NetApp slides despite delivering beats in Q3 https://seekingalpha.com/news/3331187-netapp-slides-despite-delivering-beats-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3331187-netapp-slides-despite-delivering-beats-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331177\" data-ts=\"1518644046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CF\" target=\"_blank\">CF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331177-cf-industries-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CF Industries beats by $0.06, beats on revenue</a></h4><ul><li>CF Industries (NYSE:<a href='https://seekingalpha.com/symbol/CF' title='CF Industries Holdings, Inc.'>CF</a>): Q4 EPS of -$0.02 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $1.1B (+26.9% Y/Y) <font color='green'>beats by $122.09M</font>.</li><li>Shares <font color='green'>+2.6%</font>.</li><li><a href='https://seekingalpha.com/pr/17075281-cf-industries-holdings-inc-reports-fourth-quarter-net-earnings-465-million-ebitda-224-million'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331177\" data-linked=\"CF Industries beats by $0.06, beats on revenue\" data-tweet=\"$CF - CF Industries beats by $0.06, beats on revenue https://seekingalpha.com/news/3331177-cf-industries-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331177-cf-industries-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331162\" data-ts=\"1518643484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331162-tripadvisor-soars-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TripAdvisor soars after earnings</a></h4><ul>     <li>TripAdvisor (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a>) flew past revenue and EBITDA estimates with its Q4 report.</li>     <li>The company also kicked up EBITDA of $63M during the quarter vs. $51M consensus. EBITDA margin rose two percentage points to 20.0% compared to a year ago.</li>     <li>TripAdvisor says its click-based auction results generally stabilized during the quarter and online acquisition costs fell back.</li>     <li>TripAdvisor says it plans to buy up to $250M worth of its shares.</li>     <li>2018 TripAdvior outlook: \"We expect 2018 consolidated revenue and adjusted EBITDA year-over-year performance will be second half-weighted, driven by brand marketing investments in the first half of the year that were not in the year-ago period, as well as by tough year-over-year comparisons in our click-based and transaction business.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331145-tripadvisor-misses-0_08-beats-revenue\" target=\"_blank\">TripAdvisor misses by $0.08, beats on revenue</a> (Feb. 14)</li><li>TRIP&nbsp;<font color='green'>+18%</font>&nbsp;AH to $48.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331162\" data-linked=\"TripAdvisor soars after earnings\" data-tweet=\"$TRIP - TripAdvisor soars after earnings https://seekingalpha.com/news/3331162-tripadvisor-soars-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3331162-tripadvisor-soars-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331161\" data-ts=\"1518643476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331161-applied-materialsplus-3-after-record-sales-drive-beats-doubled-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Materials +3% after record sales drive beats, doubled dividend</a></h4><ul>   <li>Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) is <font color='green'>up 3%</font> in heavy after-hours volume following a <a href=\"https://seekingalpha.com/pr/17075163-applied-materials-delivers-strong-year-year-growth-quarterly-revenue-operating-profit\" target=\"_blank\">fiscal Q1 earnings report</a> that featured outsized current-quarter guidance to go with a beat on top and bottom lines.</li>    <li>Revenue hit a quarterly record with broad gains across key product lines. Non-GAAP EPS grew 58% and hit a record of $1.06.</li>    <li>It's taking a $1B tax charge, including an estimate of a transition tax payable over eight years.</li>    <li>The company's also doubling its dividend to $0.20, and boosting share repurchase authorization by $6B -- incremental to $2.8B remaining under a previous authorization.</li>    <li>Net sales by segment: Semiconductor Systems, $2.85B (up 32.4%); Applied Global Services, $880M (up 30.2%); Display and Adjacent Markets, $455M (up 7.8%)</li>    <li>Cash flow from operations rose 85% to $1.47B.</li>    <li>For Q2, it's guiding to net sales of $4.35B-$4.55B (growth of 26% at the midpoint, and well above consensus for $4.22B) and EPS of $1.10-$1.18 (up 44% at the midpoint and well over consensus for $1.01).</li>    <li><a href=\"www.appliedmaterials.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17075163-applied-materials-delivers-strong-year-year-growth-quarterly-revenue-operating-profit\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331161\" data-linked=\"Applied Materials +3% after record sales drive beats, doubled dividend\" data-tweet=\"$AMAT - Applied Materials +3% after record sales drive beats, doubled dividend https://seekingalpha.com/news/3331161-applied-materialsplus-3-after-record-sales-drive-beats-doubled-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3331161-applied-materialsplus-3-after-record-sales-drive-beats-doubled-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331156\" data-ts=\"1518643348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEDG\" target=\"_blank\">SEDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331156-solaredgeplus-14-after-easy-q4-beat-guides-q1-revenues-above-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarEdge +14% after easy Q4 beat; guides Q1 revenues above consensus</a></h4><ul>     <li>SolarEdge Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a>)&nbsp;<font color='green'>+13.8%</font> after-hours following an easy <a href=\"https://seekingalpha.com/news/3331134-solaredge-technologies-beats-0_20-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat and a 70% Y/Y revenue increase to a company record $189M.</li>     <li>SEDG also issues upside guidance for Q1, seeing revenues of $200M-$210M vs. $157M analyst consensus estimate; gross margins are forecast to come in at 36%-38%.</li>     <li>SEDG says Q4 GAAP gross margin reached 37.5%, up from 34.9% in Q3 and up from 35% Y/Y; cash flow from operating activities was $45.8M, up from $33.6M in Q3 and $24.7M in the year-ago quarter.</li><li>\"We grew our revenues in each of the geographies in which we operate and overcame a challenging year in terms of industry-wide component availability and growing our  manufacturing capacity to support the growing demand for our products,\"&nbsp;SEDG says.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3331156\" data-linked=\"SolarEdge +14% after easy Q4 beat; guides Q1 revenues above consensus\" data-tweet=\"$SEDG - SolarEdge +14% after easy Q4 beat; guides Q1 revenues above consensus https://seekingalpha.com/news/3331156-solaredgeplus-14-after-easy-q4-beat-guides-q1-revenues-above-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3331156-solaredgeplus-14-after-easy-q4-beat-guides-q1-revenues-above-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331151\" data-ts=\"1518643214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331151-teva-up-7-after-hours-on-berkshire-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva up 7% after hours on Berkshire stake</a></h4><ul><li>CNBC <a href=\"https://www.cnbc.com/2018/02/14/teva-shares-jump-11-percent-after-berkshire-reports-358-million-stake.html\" target=\"_blank\">reports </a>that Warren Buffett's Berkshire Hathaway has established a $358M stake in Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>). Shares are up&nbsp;<font color='green'>7%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331151\" data-linked=\"Teva up 7% after hours on Berkshire stake\" data-tweet=\"$TEVA - Teva up 7% after hours on Berkshire stake https://seekingalpha.com/news/3331151-teva-up-7-after-hours-on-berkshire-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3331151-teva-up-7-after-hours-on-berkshire-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>139&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331145\" data-ts=\"1518643071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331145-tripadvisor-eps-of-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TripAdvisor EPS of $0.06, beats on revenue</a></h4><ul><li>TripAdvisor (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a>): Q4 Adj. EPS of $0.06 may not be comparable to consensus of $0.14.</li><li>Revenue of $321M (+1.6% Y/Y) <font color='green'>beats by $8.83M</font>.</li><li>Shares <font color='green'>+15%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17075164-tripadvisor-inc-earnings-press-release-available-companys-investor-relations-site\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331145\" data-linked=\"TripAdvisor EPS of $0.06, beats on revenue\" data-tweet=\"$TRIP - TripAdvisor EPS of $0.06, beats on revenue https://seekingalpha.com/news/3331145-tripadvisor-eps-of-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331145-tripadvisor-eps-of-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331144\" data-ts=\"1518643035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CC\" target=\"_blank\">CC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331144-chemours-beats-0_22-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chemours beats by $0.22, beats on revenue</a></h4><ul><li>Chemours (NYSE:<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a>): Q3 EPS of $1.19 <font color='green'>beats by $0.22</font>.</li><li>Revenue of $1.58B (+19.7% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+1.2%</font>.</li><li><a href='https://seekingalpha.com/pr/17075264-chemours-company-reports-fourth-quarter-full-year-2017-results-robust-performance-across'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331144\" data-linked=\"Chemours beats by $0.22, beats on revenue\" data-tweet=\"$CC - Chemours beats by $0.22, beats on revenue https://seekingalpha.com/news/3331144-chemours-beats-0_22-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331144-chemours-beats-0_22-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331139\" data-ts=\"1518642935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331139-ciscoplus-5_7-after-q2-beats-upside-q3-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco +5.7% after Q2 beats, upside Q3 guidance</a></h4><ul>   <li>Cisco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) is <font color='green'>up 5.7%</font> after hours in early going after <a href=\"https://seekingalpha.com/news/3331121-cisco-beats-0_04-beats-revenue\" target=\"_blank\">fiscal Q2 earnings</a> beat on top and bottom lines and guidance for current-quarter profits runs ahead of consensus.</li>    <li>The company posted a net loss of $8.8B vs. a year-ago gain of $2.3B, though those results included an $11.1B charge tied to tax reform ($9B for U.S. transition tax, $1.2B for foreign withholding and $0.9B to remeasure deferred tax assets).</li>    <li>On a non-GAAP basis, net income rose to $3.1B from $2.9B, and EPS went up 11% to $0.63.</li>    <li>It also boosted its quarterly dividend by $0.04 (14%) to $0.33/share, and increased its stock repurchase authorization by $25B with no fixed termination date (that brings total authorized amount to $31B).</li>    <li>Revenue breakout: Product, $8.71B (up 2.6%); Servie, $3.18B (up 2.9%).</li>    <li>For Q3, it's guiding to 3-5% revenue growth, gross margin of 63-64%, operating margin of 29.5-30.5%, and EPS of $0.64-$0.66 (above consensus for $0.63).</li>    <li><a href=\"https://investor.cisco.com/\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17075213-cisco-reports-second-quarter-earnings\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331139\" data-linked=\"Cisco +5.7% after Q2 beats, upside Q3 guidance\" data-tweet=\"$CSCO - Cisco +5.7% after Q2 beats, upside Q3 guidance https://seekingalpha.com/news/3331139-ciscoplus-5_7-after-q2-beats-upside-q3-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331139-ciscoplus-5_7-after-q2-beats-upside-q3-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331133\" data-ts=\"1518642710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHN\" target=\"_blank\">ATHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331133-athenahealth-sees-revenues-high-1_38b-this-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenahealth sees revenues as high as $1.38B this year</a></h4><ul><li>At its <a href=\"https://seekingalpha.com/pr/17075170-athenahealth-provides-guidance-fiscal-year-2018-investor-summit\" target=\"_blank\">Investor Summit</a>, athenahealth (<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a> <font color='green'>+5.6%</font>) provided guidance for 2018:</li><li>Revenues: $1.31B - 1.38B; operating income: $108M - 152M; non-GAAP operating income: $210M - 235M.</li><li>Key focus areas:</li><li>Drive top-line growth in core services and build on network services.</li><li>Balance service automation with investments in client work reduction efforts.</li><li>Invest in R&amp;D to support product, technology and platform strategies.</li><li>Improve efficiency and increase scale across the business.</li><li>Increase operating margin and cash flow ops.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331133\" data-linked=\"Athenahealth sees revenues as high as $1.38B this year\" data-tweet=\"$ATHN - Athenahealth sees revenues as high as $1.38B this year https://seekingalpha.com/news/3331133-athenahealth-sees-revenues-high-1_38b-this-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3331133-athenahealth-sees-revenues-high-1_38b-this-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331123\" data-ts=\"1518642467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/A\" target=\"_blank\">A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331123-agilent-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agilent beats by $0.08, beats on revenue</a></h4><ul><li>Agilent (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies Inc.'>A</a>): Q1 EPS of $0.66 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $1.21B (+14.2% Y/Y) <font color='green'>beats by $50M</font>.</li><li>Shares <font color='green'>+2.4%</font>.</li><li><a href='https://seekingalpha.com/pr/17075194-agilent-technologies-reports-first-quarter-fiscal-year-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331123\" data-linked=\"Agilent beats by $0.08, beats on revenue\" data-tweet=\"$A - Agilent beats by $0.08, beats on revenue https://seekingalpha.com/news/3331123-agilent-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331123-agilent-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331121\" data-ts=\"1518642387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331121-cisco-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco beats by $0.04, beats on revenue</a></h4><ul><li>Cisco (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>): Q2 EPS of $0.63 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $11.88B (+2.6% Y/Y) <font color='green'>beats by $70M</font>.</li><li>Shares <font color='green'>+3%</font>.</li><li><a href='https://seekingalpha.com/pr/17075213-cisco-reports-second-quarter-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331121\" data-linked=\"Cisco beats by $0.04, beats on revenue\" data-tweet=\"$CSCO - Cisco beats by $0.04, beats on revenue https://seekingalpha.com/news/3331121-cisco-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331121-cisco-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331117\" data-ts=\"1518642299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331117-amicus-therapeutics-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus Therapeutics readies stock offering</a></h4><ul><li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) <a href=\"https://seekingalpha.com/pr/17075172-amicus-therapeutics-announces-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331117\" data-linked=\"Amicus Therapeutics readies stock offering\" data-tweet=\"$FOLD - Amicus Therapeutics readies stock offering https://seekingalpha.com/news/3331117-amicus-therapeutics-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3331117-amicus-therapeutics-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331111\" data-ts=\"1518641251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOC\" target=\"_blank\">NOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331111-northrop-grumman-upgraded-jefferies-on-orbital-atk-deal-benefits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northrop Grumman upgraded at Jefferies on Orbital ATK deal benefits</a></h4><ul>     <li>Northrop Grumman (<a href='https://seekingalpha.com/symbol/NOC' title='Northrop Grumman Corporation'>NOC</a> <font color='green'>+2%</font>)&nbsp;is higher after Jefferies <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11200346/jefferies-orbital-atk-acquisition-strengthens-northrop-\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $400 price target, hiked from $345, with the case for owning the stock strengthened by <a href=\"https://seekingalpha.com/news/3330549-europe-approves-northrop-orbital-atk-deal\" target=\"_blank\">yesterday's approval</a> of the acquisition of Orbital ATK by European regulators.</li>     <li>If the addition of Orbital ATK generates $200M, or 5%, in cost synergies and accelerated revenue growth, the deal could add as much as $2.30/share in 2020, Jefferies says.</li>     <li>The firm also thinks the deal gives NOC a competitive position on the Ground Based Strategic Deterrent program, an $85B initiative to modernize intercontinental ballistic missiles that could be worth $15/share alone.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331111\" data-linked=\"Northrop Grumman upgraded at Jefferies on Orbital ATK deal benefits\" data-tweet=\"$NOC - Northrop Grumman upgraded at Jefferies on Orbital ATK deal benefits https://seekingalpha.com/news/3331111-northrop-grumman-upgraded-jefferies-on-orbital-atk-deal-benefits?source=tweet\" data-url=\"https://seekingalpha.com/news/3331111-northrop-grumman-upgraded-jefferies-on-orbital-atk-deal-benefits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331108\" data-ts=\"1518640599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTEN\" target=\"_blank\">PTEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331108-patterson-uti-energy-upgraded-bmo-20-recent-dropoff-unjustified\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Patterson-UTI Energy upgraded at BMO as 20% recent dropoff unjustified</a></h4><ul>     <li>Patterson-UTI&nbsp;Energy (<a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color='green'>+3.1%</font>) is higher after BMO&nbsp;Capital <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11199223/patterson-uti-energy-is-among-the-most-oversold-stocks-\" target=\"_blank\">upgrades</a> shares to Outperform from Market Perform with a $26 price target, noting the stock's ~20% fall since PTEN's <a href=\"https://seekingalpha.com/news/3329553-patterson-uti-energy-minus-13-percent-amid-uncertainty-deadly-accident\" target=\"_blank\">Q4 earnings</a> release.</li>     <li>BMO believes PTEN's fundamentals are improving, and management's commentary of adding up to 200 rigs at year-end compared to 2017 implies the potential for upside to consensus estimates in H2 2018.</li>     <li>While the absence of a dividend increase was disappointing, BMO says the ensuing selloff was unwarranted, and the firm estimates PTEN's free cash flow yield for 2018 at 3.7%, which would rank it as one of the highest within the land-drilling space and possibly causing a 50% dividend increase in the future.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331108\" data-linked=\"Patterson-UTI Energy upgraded at BMO as 20% recent dropoff unjustified\" data-tweet=\"$PTEN - Patterson-UTI Energy upgraded at BMO as 20% recent dropoff unjustified https://seekingalpha.com/news/3331108-patterson-uti-energy-upgraded-bmo-20-recent-dropoff-unjustified?source=tweet\" data-url=\"https://seekingalpha.com/news/3331108-patterson-uti-energy-upgraded-bmo-20-recent-dropoff-unjustified\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331104\" data-ts=\"1518639547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331104-vipshop-continues-post-earnings-runplus-8_4-amid-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop continues post-earnings run, +8.4% amid upgrades</a></h4><ul>   <li>Vipshop Holdings (NYSE:<a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a>) is <font color='green'>up another 8.4%</font>, continuing a run from <a href=\"https://seekingalpha.com/news/3330320-vipshop-plus-11_7-percent-q4-growth-customers-average-revenues\" target=\"_blank\">Monday's earnings report</a>, as analysts boost ratings.</li>    <li>Shares are <font color='green'>up 23.5%</font> over the three days.</li>    <li>HSBC has upgraded the ADRs to Buy from Hold, and raised its price target to $20 from $12, implying 14% upside from the last close.</li>    <li>Meanwhile, Macquarie has upgraded Vipshop to Outperform as well. And China Renaissance has boosted its rating to Buy from Hold, with a price target of $21 (17% upside from last close).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331104\" data-linked=\"Vipshop continues post-earnings run, +8.4% amid upgrades\" data-tweet=\"$VIPS - Vipshop continues post-earnings run, +8.4% amid upgrades https://seekingalpha.com/news/3331104-vipshop-continues-post-earnings-runplus-8_4-amid-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3331104-vipshop-continues-post-earnings-runplus-8_4-amid-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331102\" data-ts=\"1518639351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331102-teck-predicts-strong-demand-for-steelmaking-coal-this-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck predicts strong demand for steelmaking coal this year</a></h4><ul>     <li>Teck Resources (<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='green'>+2.3%</font>) says it expects growing global steel production to <a href=\"https://www.reuters.com/article/teck-resources-results/update-3-teck-sees-strong-demand-for-steelmaking-coal-in-2018-idUSL4N1Q43IG\" target=\"_blank\">boost demand for its steelmaking coal</a> in 2018, and believes the company is well positioned to benefit from continued strength in commodity prices.</li>     <li>Teck is &ldquo;feeling pretty good about 2018&rdquo; after reporting in-line financial results, CEO Don Lindsay said during today's earnings conference call, and steelmaking coal demand is expected to keep climbing in 2018 while ongoing logistics and production issues at key Australian mines support prices.</li>     <li>Teck forecasts steelmaking coal production of 26M-27M metric tons in 2018 and 26.5M-27.5M metric tons in 2019-22 despite this year&rsquo;s closure of its Coal Mountain operations.</li>     <li>Shares of Teck, up nearly 15% YTD, are more than 2% higher after rebounding from <a href=\"https://seekingalpha.com/news/3330963-teck-resources-minus-4-percent-disappointing-q4-results\" target=\"_blank\">steep early losses</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331102\" data-linked=\"Teck predicts strong demand for steelmaking coal this year\" data-tweet=\"$TECK - Teck predicts strong demand for steelmaking coal this year https://seekingalpha.com/news/3331102-teck-predicts-strong-demand-for-steelmaking-coal-this-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3331102-teck-predicts-strong-demand-for-steelmaking-coal-this-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331099\" data-ts=\"1518638732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331099-biogen-slides-6-after-alzheimer-study-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen slides 6% after Alzheimer study news</a></h4><ul><li><a href=\"https://twitter.com/zbiotech/status/963863489415647235\" target=\"_blank\">via @zbiotech</a></li><li>Presenting at the Leerink Partners conference, management says it's sizing up by about 510 patients its&nbsp;aducanumab trials due to \"increased variability.\"</li><li><a href=\"http://investors.biogen.com/event/webcast/biogen-leerink-partners-7th-annual-global-healthcare-conference\" target=\"_blank\">Webcast here</a></li><li><a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>&nbsp;<font color='red'>-6.2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3331099\" data-linked=\"Biogen slides 6% after Alzheimer study news\" data-tweet=\"$BIIB - Biogen slides 6% after Alzheimer study news https://seekingalpha.com/news/3331099-biogen-slides-6-after-alzheimer-study-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3331099-biogen-slides-6-after-alzheimer-study-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331095\" data-ts=\"1518638337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HICKA\" target=\"_blank\">HICKA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331095-hickok-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hickok reports Q1 results</a></h4><ul><li>Hickok (<a href='https://seekingalpha.com/symbol/HICKA' title='Hickok Inc. A'>OTCQB:HICKA</a>): Q1 EPS of $0.16</li><li>Revenue of $11.75M (+397.9% Y/Y)</li><li>Shares <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/pr/17075106-hickok-incorporated-reports-results-three-months-ended-december-31-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331095\" data-linked=\"Hickok reports Q1 results\" data-tweet=\"$HICKA $CRAWA - Hickok reports Q1 results https://seekingalpha.com/news/3331095-hickok-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3331095-hickok-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331094\" data-ts=\"1518638207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTO\" target=\"_blank\">CRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331094-technology-top-gainers-losers-of-2_55-pm-2-14-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (2/14/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CARB' title='Carbonite Inc.'>CARB</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+18%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LXFT' title='Luxoft Holding Inc'>LXFT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331094\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (2/14/18)\" data-tweet=\"$CRTO $CRTO $CCIH - Technology - Top Gainers / Losers as of 2.55 pm (2/14/18) https://seekingalpha.com/news/3331094-technology-top-gainers-losers-of-2_55-pm-2-14-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3331094-technology-top-gainers-losers-of-2_55-pm-2-14-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331093\" data-ts=\"1518638104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331093-bunge-says-interested-parties-for-sugar-trading-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bunge says has &#39;interested parties&#39; for sugar trading business</a></h4><ul>     <li>Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='red'>-6.2%</font>) now sinks more than 6% following <a href=\"https://seekingalpha.com/news/3330938-bunges-sharp-q4-miss-adds-questions-companys-future\" target=\"_blank\">disappointing Q4 results</a> and its worst annual profit reading since 2009.</li>     <li>BG says it is getting out of sugar trading and distribution and has identified a few interested parties for the business, but Citigroup's David Driscoll says sugar trading has been \"<a href=\"https://www.reuters.com/article/bunge-results-sugar/update-2-bunge-exits-sugar-trading-business-has-interested-parties-ceo-idUSL2N1Q40ZP\" target=\"_blank\">historically positive</a>&rdquo; for the company - &ldquo;I&lsquo;m not exactly clear why you&rsquo;d really want to shut that one down,&rdquo; the analyst said during today's earnings conference call.</li>     <li>CEO&nbsp;Soren Schroder said BG has struggled to generate enough gross margin to cover costs in sugar, and &ldquo;we simply decided that it was time to really focus on what&rsquo;s core to us, which is agribusiness, foods, grains and oilseeds and get on with it in a good way.\"</li>     <li>BG's Brazilian sugar milling business - which the company has been seeking to exit since 2013, as a supply glut has pushed prices lower and made it tough to turn a profit - will &ldquo;have its own direction&rdquo; from the trading business, Schroder said.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331093\" data-linked=\"Bunge says has &#39;interested parties&#39; for sugar trading business\" data-tweet=\"$BG - Bunge says has &#39;interested parties&#39; for sugar trading business https://seekingalpha.com/news/3331093-bunge-says-interested-parties-for-sugar-trading-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3331093-bunge-says-interested-parties-for-sugar-trading-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331090\" data-ts=\"1518636308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331090-twilioplus-19-q4-revenues-guidance-beat-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio +19% as Q4 revenues, guidance beat expectations</a></h4><ul>     <li>Twilio (<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+18.7%</font>) skyrockets nearly 20%, reaching its best intraday level in more than three months, after the cloud communications company reported a <a href=\"https://seekingalpha.com/news/3330737-twilio-plus-5_7-percent-q4-beats-mixed-guidance\" target=\"_blank\">narrower than expected Q4 loss</a> and a 41% Y/Y revenue increase.</li>     <li>Excluding the impact from lower Uber orders - which now account for 5% of TWLO's quarterly sales - TWLO's Q4 base revenue rose 62% Y/Y.</li>     <li>TWLO forecasts Q4 revenues of $115M-$117M vs. $108M analyst consensus estimate, and revenues of $506M-$514M vs. $481M consensus for the full year.</li>     <li>TWLO also produced $3.2M of free cash flow in Q4 vs. a $6M cash burn in the year-ago period; it was the company's first positive free cash flow result since Q1 2016.</li>     <li>Canaccord <a href=\"https://www.barrons.com/articles/tech-today-twilio-soars-talend-surges-mulling-apple-cash-scenarios-1518627733\" target=\"_blank\">reiterates its Buy rating</a> and $38 price target, citing three takeaways: growth among bread-and-butter customers remains robust, the forecast leaves room for upside&rdquo; this year, and the installation of several new key executives means TWLO is &ldquo;ready for the next leg of its go-to-market evolution,&rdquo; which could in turn bring more enterprise adoption of its product.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331090\" data-linked=\"Twilio +19% as Q4 revenues, guidance beat expectations\" data-tweet=\"$TWLO - Twilio +19% as Q4 revenues, guidance beat expectations https://seekingalpha.com/news/3331090-twilioplus-19-q4-revenues-guidance-beat-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3331090-twilioplus-19-q4-revenues-guidance-beat-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331087\" data-ts=\"1518635967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331087-stocks-ignore-rising-rates-shoot-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks ignore rising rates, shoot higher</a></h4><ul><li>This morning's speedy CPI report has helped send the 10-year Treasury yield to another cycle high, up 7.3 basis points to 2.902%.</li><li>Stocks have gone back to ignoring higher interest rates though, with the Nasdaq&nbsp;<font color='green'>up 1.6%</font>, the S&amp;P 500&nbsp;<font color='green'>1.15%</font>, and the Dow&nbsp;<font color='green'>0.8%</font>.</li><li>Gold and oil are on the move as well, each up about 2%.</li><li>Bitcion too is joining the action,&nbsp;<font color='green'>up 7.8%</font>&nbsp;to $9.2K.</li><li>What's not working? Utilities (<a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='red'>-0.7%</font>) and REITs (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-0.6%</font>), (<a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a> <font color='red'>-0.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3331087\" data-linked=\"Stocks ignore rising rates, shoot higher\" data-tweet=\"$XLU $IYR $VNQ - Stocks ignore rising rates, shoot higher https://seekingalpha.com/news/3331087-stocks-ignore-rising-rates-shoot-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3331087-stocks-ignore-rising-rates-shoot-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331080\" data-ts=\"1518634829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331080-energy-materials-top-gainers-losers-of-2-00-pm-2-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/14/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corporation'>AXU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SA' title='Seabridge Gold Inc'>SA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CGA' title='China Green Agriculture, Inc.'>CGA</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331080\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/14/2018)\" data-tweet=\"$RKDA $RKDA $PES - Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/14/2018) https://seekingalpha.com/news/3331080-energy-materials-top-gainers-losers-of-2-00-pm-2-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331080-energy-materials-top-gainers-losers-of-2-00-pm-2-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331076\" data-ts=\"1518634279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331076-buckle-tight-for-shopify-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckle tight for Shopify earnings</a></h4><ul> <li>The dueling opinions on battleground stock Shopify (<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a> <font color='green'>+7.9%</font>) will get a test tomorrow when the company reports Q4 earnings. The fireworks are expected to go off about 8:00 a.m. EST.</li> <li>Consensus estimates are for Shopify to disclose revenue of $210M and EPS of $0.05 for the quarter.</li> <li>D.A. Davidson says investors will be listening to the conference call carefully to dissect the upside from the Shopify Plus platform and the impact of the new variable-rate pricing model.</li> <li>A high level of short interest on Shopify is likely to lead to a sharp post-earnings swing up or down as traders scramble.</li><li>Shares of Shopify hit a new high of $137.94 earlier today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331076\" data-linked=\"Buckle tight for Shopify earnings\" data-tweet=\"$SHOP - Buckle tight for Shopify earnings https://seekingalpha.com/news/3331076-buckle-tight-for-shopify-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3331076-buckle-tight-for-shopify-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331072\" data-ts=\"1518632870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCRX\" target=\"_blank\">PCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331072-pacira-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacira shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Pacira Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='green'>+0.6%</font>) pending the release of news.</li><li>An FDA advisory committee is meeting today and tomorrow to review its marketing application for pain med EXPAREL.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330253-fda-ad-com-week-paciras-exparel\" target=\"_blank\">FDA Ad Com this week for Pacira's Exparel</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331072\" data-linked=\"Pacira shares halted pending news\" data-tweet=\"$PCRX - Pacira shares halted pending news https://seekingalpha.com/news/3331072-pacira-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3331072-pacira-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331071\" data-ts=\"1518632564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DYNT\" target=\"_blank\">DYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331071-dynatronics-completes-round-trip-after-fq2-results-down-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynatronics completes round-trip after FQ2 results, down 16%</a></h4><ul><li>Thinly traded nano cap Dynatronics (<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='red'>-16.1%</font>) has retraced the gains from earlier in the week after posting <a href=\"https://seekingalpha.com/pr/17073865-dynatronics-announces-107_5-percent-increase-top-line-sales-fiscal-2018-second-quarter\" target=\"_blank\">fiscal Q2 results</a>.</li><li>Sales were up 108% to $18.1M, due in large part from recent acquisitions which contributed $10.1M. Organic growth was down 8% to $8.0M.</li><li>Net loss widened to ($1.3M). Cash and equivalents at quarter-end were $3.7M. Accounts receivable increased 37% to $7.2M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331071\" data-linked=\"Dynatronics completes round-trip after FQ2 results, down 16%\" data-tweet=\"$DYNT - Dynatronics completes round-trip after FQ2 results, down 16% https://seekingalpha.com/news/3331071-dynatronics-completes-round-trip-after-fq2-results-down-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3331071-dynatronics-completes-round-trip-after-fq2-results-down-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331070\" data-ts=\"1518632023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331070-oktaplus-6_2-bullish-needham-sees-expanding-lead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Okta +6.2% as bullish Needham sees expanding lead</a></h4><ul>   <li>Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) is <font color='green'>up 6.2%</font> after a bullish start at Needham, which initiated shares with a Buy rating.</li>    <li>\"We expect Okta to <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11197757/okta-has-a-competitive-advantage-needham-says-in-bullis\" target=\"_blank\">continue to extend their lead</a> over competitors as the scale of their partnerships and the expansion of their customer base outpace alternatives and amplify Okta's competitive advantage,\" writes analyst Alex Henderson.</li>    <li>That expansion comes in a total addressable market of $18B and growing, he says, and about 92% of enterprises surveyed are considering upgrading their identity posture.</li>    <li>Its pure Software-as-a-Service model should deliver consistency associated with the best of the breed in SaaS, Henderson says.</li>    <li>He started with a price target of $38, implying 13.3% upside from today's higher price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331070\" data-linked=\"Okta +6.2% as bullish Needham sees expanding lead\" data-tweet=\"$OKTA - Okta +6.2% as bullish Needham sees expanding lead https://seekingalpha.com/news/3331070-oktaplus-6_2-bullish-needham-sees-expanding-lead?source=tweet\" data-url=\"https://seekingalpha.com/news/3331070-oktaplus-6_2-bullish-needham-sees-expanding-lead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331068\" data-ts=\"1518631253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCC\" target=\"_blank\">IPCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331068-financials-top-5-gainers-losers-of-1-00-pm-02-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (02/14/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IPCC' title='Infinity Property and Casualty Corporation'>IPCC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/RM' title='Regional Management Corp.'>RM</a> <font color='green'>+15%</font>.<a href='https://seekingalpha.com/symbol/CIGI' title='Colliers International Group Inc.'>CIGI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KMPR' title='Kemper Corporation'>KMPR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FSP' title='Franklin Street Properties Corp'>FSP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331068\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (02/14/2018)\" data-tweet=\"$IPCC $IPCC $RM - Financials - Top 5 Gainers / Losers as of 1:00 PM (02/14/2018) https://seekingalpha.com/news/3331068-financials-top-5-gainers-losers-of-1-00-pm-02-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331068-financials-top-5-gainers-losers-of-1-00-pm-02-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331063\" data-ts=\"1518631182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331063-omeros-continues-slide-down-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros continues slide, down 20%</a></h4><ul><li>Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-20.4%</font>) slumps on almost a 6x surge in volume. Shares have lost close to half their value in a month.</li><li>This morning, investor FourWorld Capital Management, LLC published a <a href=\"https://seekingalpha.com/pr/17074666-fourworld-capital-issues-eye-opening-research-report-drugmaker-omeros-concludes-company-faces\" target=\"_blank\">bearish report </a>supporting its view that the stock is worth only $4/share (63% downside risk).</li><li>FourWorld says Medicare reimbursement for top-seller Omidria (phenylephrine and ketorolac intraocular solution) has not been extended in 2018 which will take down its $465/dose price with it. It also claims that the company has been repurchasing Omidria inventory from customers at full price.</li><li>At the end of September 2017, the company had almost $87M in quick assets. Operations consumed ~$10M in cash each quarter through calendar Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331063\" data-linked=\"Omeros continues slide, down 20%\" data-tweet=\"$OMER - Omeros continues slide, down 20% https://seekingalpha.com/news/3331063-omeros-continues-slide-down-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3331063-omeros-continues-slide-down-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331062\" data-ts=\"1518630322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOSL\" target=\"_blank\">FOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331062-midday-gainers-losers-2-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (2/14/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/IPCC' title='Infinity Property and Casualty Corporation'>IPCC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/LAYN' title='Layne Christensen Company'>LAYN</a> <font color='green'>+19%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a> <font color='red'>-59%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='red'>-53%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-40%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LXFT' title='Luxoft Holding Inc'>LXFT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331062\" data-linked=\"Midday Gainers / Losers (2/14/2018)\" data-tweet=\"$FOSL $FOSL $ZSAN - Midday Gainers / Losers (2/14/2018) https://seekingalpha.com/news/3331062-midday-gainers-losers-2-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331062-midday-gainers-losers-2-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331061\" data-ts=\"1518629390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLND\" target=\"_blank\">TLND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331061-talendplus-10-on-strong-revenue-outlook-q4-billings-boom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talend +10% on strong revenue outlook, Q4 &#39;billings boom&#39;</a></h4><ul>     <li>Cloud software maker Talend (<a href='https://seekingalpha.com/symbol/TLND' title='Talend SA'>TLND</a> <font color='green'>+9.7%</font>) surges following in-line <a href=\"https://seekingalpha.com/news/3330704-talend-beats-0_01-revenue-line\" target=\"_blank\">Q4 earnings</a> but a 36% Y/Y revenue increase and a better than expected outlook for the full year.</li>     <li>TLND forecasts FY&nbsp;2017 revenue of $200M-$202M and a net per share loss of $0.44-$0.48 vs. analyst consensus for $193M in revenues and a $0.45 loss.</li>     <li>TLND says its &ldquo;cloud subscription&rdquo; revenue more than doubled, with strong gains in subscription revenue from Asia-Pacific due to the company&rsquo;s continued international expansion.</li>     <li>\"Our sales reps set a <a href=\"https://www.barrons.com/articles/talend-q4-net-loss-smaller-than-expected-revenue-outlook-beats-1518557768\" target=\"_blank\">new record for sales productivity</a> this quarter - the sales per person was higher than it&rsquo;s ever been,\" CEO&nbsp;Mike Tuchen tells <em>Barron's</em>, adding that \"while some companies see productivity slowing, ours is actually accelerating. Our products&nbsp;are clearly differentiated for these new use cases, and that&rsquo;s helping to make them&nbsp;easier to sell.\"</li>     <li>BTIG&nbsp;Research's Edward Parker, who rates TLND as a Buy with a $52 price target, says the big news in the quarter was a \"<a href=\"http://www.barrons.com/articles/tech-today-twilio-soars-talend-surges-mulling-apple-cash-scenarios-1518627733\" target=\"_blank\">billings boom</a>\" of $62.1M, beating his expectations of $46.3M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331061\" data-linked=\"Talend +10% on strong revenue outlook, Q4 &#39;billings boom&#39;\" data-tweet=\"$TLND - Talend +10% on strong revenue outlook, Q4 &#39;billings boom&#39; https://seekingalpha.com/news/3331061-talendplus-10-on-strong-revenue-outlook-q4-billings-boom?source=tweet\" data-url=\"https://seekingalpha.com/news/3331061-talendplus-10-on-strong-revenue-outlook-q4-billings-boom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331060\" data-ts=\"1518629309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331060-commscopeplus-3-barclays-moves-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope +3% as Barclays moves to Overweight</a></h4><ul>   <li>CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company Inc.'>COMM</a>) is <font color='green'>up 3%</font> ahead of earnings tomorrow after an upgrade to Overweight at Barclays, from Equal Weight.</li>    <li>The firm ticked up its price target to $43, implying 10.7% upside from here.</li>    <li>Earnings are expected before the open tomorrow; consensus expectations have it logging earnings per share of $0.47 on revenues of $1.11B, with EBITDA of $215M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331060\" data-linked=\"CommScope +3% as Barclays moves to Overweight\" data-tweet=\"$COMM - CommScope +3% as Barclays moves to Overweight https://seekingalpha.com/news/3331060-commscopeplus-3-barclays-moves-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3331060-commscopeplus-3-barclays-moves-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331056\" data-ts=\"1518628273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLGT\" target=\"_blank\">TLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331056-fda-oks-teligents-generic-steroid-lotion-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Teligent&#39;s generic steroid lotion; shares up 1%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17074799-teligent-inc-announces-fda-approval-betamethasone-dipropionate-lotion-usp-augmented-0_05\" target=\"_blank\">approves </a>Teligent's (<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color='green'>+1%</font>) generic betamethasone dipropionate lotion USP (Augmented) 0.05%, a topical steroid lotion for treating dermatitis-related conditions.</li><li>According to IQVIA, the U.S. market is ~$20M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331056\" data-linked=\"FDA OKs Teligent&#39;s generic steroid lotion; shares up 1%\" data-tweet=\"$TLGT - FDA OKs Teligent&#39;s generic steroid lotion; shares up 1% https://seekingalpha.com/news/3331056-fda-oks-teligents-generic-steroid-lotion-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3331056-fda-oks-teligents-generic-steroid-lotion-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331051\" data-ts=\"1518627734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331051-report-facebook-aiming-for-july-release-of-two-smart-speakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Facebook aiming for July release of two smart speakers</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+2.3%</font>) is targeting July for the <a href=\"https://www.digitimes.com/news/a20180214PD207.html\" target=\"_blank\">launch of two smart speakers</a>, according to a DigiTimes report.</li>    <li>That's reportedly pushed later than an originally planned May release, so that Facebook can work on sound quality and software modification.</li>    <li>The speakers are code-named Aloha and Fiona; while Aloha is more sophisticated, each one will have a 15-inch touch screen a la Amazon's (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+1.6%</font>) Echo Show (though the Show has a smaller 7-inch touch screen) and promise video chat and social features as a way to stay in touch.</li>    <li>The Aloha model will be marketed under the name Portal and use voice commands along with facial recognition to access Facebook, according to the report.</li>    <li>Amazon's Echo Show lists for $229.99 and is currently on sale for $179.99.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330936-buy-dip-now-says-facebook-bull\" target=\"_blank\">Buy the dip now, says Facebook bull</a> (Feb. 14 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331051\" data-linked=\"Report: Facebook aiming for July release of two smart speakers\" data-tweet=\"$AMZN $AMZN $FB - Report: Facebook aiming for July release of two smart speakers https://seekingalpha.com/news/3331051-report-facebook-aiming-for-july-release-of-two-smart-speakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3331051-report-facebook-aiming-for-july-release-of-two-smart-speakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331049\" data-ts=\"1518627661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOSL\" target=\"_blank\">FOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331049-consumer-top-gainers-losers-of-12-00-pm-2-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (2/14/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/ACCO' title='ACCO Brands Corporation'>ACCO</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a> <font color='green'>+8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331049\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (2/14/2018)\" data-tweet=\"$FOSL $FOSL $ACCO - Consumer - Top Gainers / Losers as of 12:00 pm (2/14/2018) https://seekingalpha.com/news/3331049-consumer-top-gainers-losers-of-12-00-pm-2-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331049-consumer-top-gainers-losers-of-12-00-pm-2-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331046\" data-ts=\"1518626845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AR\" target=\"_blank\">AR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331046-antero-resourcesplus-2_5-following-q4-earnings-beat-record-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Resources +2.5% following Q4 earnings beat, record production</a></h4><ul>     <li>Antero Resources (<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color='green'>+2.6%</font>) pushes higher after easily beating <a href=\"https://seekingalpha.com/news/3330730-antero-resources-beats-0_14-beats-revenue\" target=\"_blank\">Q4 earnings</a> expectations, as net gas equiv. production averaged a record 2.35B cfe/day, an 18% increase over the prior-year period.</li>     <li>Q4 liquids production averaged 107,433 bbl/day, up 24% Y/Y, and contributed 41% of total product revenues before hedging.</li>     <li>Proved reserves increased 12% to 17.3T cfe at year-end 2017 (36% liquids) compared to year-end 2016.</li>     <li>AR expects Q1 net production to come in flat Q/Q, citing the timing of completions throughout 2018, severe winter weather on Sherwood processing plant operations in the West Virginia Marcellus in early January, and a shutdown for several days at the Seneca plant in the Ohio Utica due to a third-party downstream pipeline rupture; AR continues to expect to meet its full-year net production guidance of ~2.7B cfe/day.</li><li>AR says it recognized a $428M deferred tax benefit in Q4 related to the reduction in the U.S. statutory tax rate to 21% from 35%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331046\" data-linked=\"Antero Resources +2.5% following Q4 earnings beat, record production\" data-tweet=\"$AR - Antero Resources +2.5% following Q4 earnings beat, record production https://seekingalpha.com/news/3331046-antero-resourcesplus-2_5-following-q4-earnings-beat-record-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3331046-antero-resourcesplus-2_5-following-q4-earnings-beat-record-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331040\" data-ts=\"1518624016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPR\" target=\"_blank\">NSPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331040-healthcare-top-5-gainers-losers-of-11-00-2-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/14/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a> <font color='red'>-59%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='red'>-48%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-41%</font>. <a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331040\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/14/2018)\" data-tweet=\"$NSPR $NSPR $DBVT - Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/14/2018) https://seekingalpha.com/news/3331040-healthcare-top-5-gainers-losers-of-11-00-2-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331040-healthcare-top-5-gainers-losers-of-11-00-2-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331032\" data-ts=\"1518623593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331032-interpublic-groupplus-11-healthy-q4-looks-to-mark-turnaround\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group +11% as healthy Q4 looks to mark turnaround</a></h4><ul>   <li>Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) is <font color='green'>up 10.7%</font> on NYSE and inching closer to a 52-week high after posting <a href=\"https://seekingalpha.com/news/3330917-interpublic-group-companies-beats-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a> that beat on top and bottom lines and portended a reversal from a slow year.</li>    <li>Revenue rose 3.5% and organic revenue was up 3.3% (up 3.7% in U.S., up 2.9% internationally).</li>    <li>Operating income was $518.3M, up from $485.7M the prior year; operating margin rose to 22.1% from 21.4%.</li>    <li>Net income was $316.6M, down slightly from $317.6M; results included a one-time $36M net benefit due to tax reform enactment.</li>    <li>Cash, equivalents and marketable securities came to $791M at Dec. 31, vs. the prior year's $1.1B. Total debt was $1.37B vs. the prior year's $1.69B.</li>    <li>The company also authorized a new buyback program for $300M in company stock; it has no expiration date. And it declared a quarterly common stock dividend of $0.21 vs. last year's $0.18.</li>    <li>\"Looking ahead to 2018, we are targeting organic revenue growth in the range of 2% to 3% and operating margin expansion of 20 basis points over the results we are reporting today, which will build on our strong long-term record of improving profitability,\" says Chairman/CEO Michael Roth.</li><li><a href=\"https://seekingalpha.com/article/4146553-interpublic-group-companies-inc-2017-q4-results-earnings-call-slides\" target=\"_blank\">Call slides</a></li>    <li><a href=\"http://www.interpublic.com/news/pressreleases?release_id=2332366\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331032\" data-linked=\"Interpublic Group +11% as healthy Q4 looks to mark turnaround\" data-tweet=\"$IPG - Interpublic Group +11% as healthy Q4 looks to mark turnaround https://seekingalpha.com/news/3331032-interpublic-groupplus-11-healthy-q4-looks-to-mark-turnaround?source=tweet\" data-url=\"https://seekingalpha.com/news/3331032-interpublic-groupplus-11-healthy-q4-looks-to-mark-turnaround\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331031\" data-ts=\"1518623587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLD\" target=\"_blank\">GLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331031-stocks-reverse-early-losses-gold-moves-sharply-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks reverse early losses; gold moves sharply higher</a></h4><ul><li>Stock index futures <a href=\"https://seekingalpha.com/news/3330959-inflation-bogeyman-whacks-futures\" target=\"_blank\">knee-jerked sharply lower</a> following a stronger-than-expected CPI report at 8:30 ET. Anybody selling on such thin gruel got burned however, as the averages have all moved into the green in mid-morning action.</li><li>The Nasdaq is&nbsp;<font color='green'>up 0.8%</font>&nbsp;and the S&amp;P 500<font color='green'> 0.45%</font>.</li><li>Gold turned modestly lower after that CPI number, and it too has had a big reversal, now&nbsp;<font color='green'>up 1.5%</font>, and within sight of its 2018 high of about $1,360 per ounce. <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a><font color='green'> +1.4%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3331031\" data-linked=\"Stocks reverse early losses; gold moves sharply higher\" data-tweet=\"$GLD - Stocks reverse early losses; gold moves sharply higher https://seekingalpha.com/news/3331031-stocks-reverse-early-losses-gold-moves-sharply-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3331031-stocks-reverse-early-losses-gold-moves-sharply-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331027\" data-ts=\"1518623278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNX\" target=\"_blank\">ATNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331027-athenex-advancing-late-stage-studies-of-kx2minus-391-in-actinic-keratosis-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athenex advancing late-stage studies of KX2-391 in actinic keratosis; shares up 1%</a></h4><ul><li>Athenex (<a href='https://seekingalpha.com/symbol/ATNX' title='Athenex, Inc.'>ATNX</a> <font color='green'>+1.4%</font>) <a href=\"https://seekingalpha.com/pr/17074467-athenex-announces-early-completion-patients-enrollment-two-phase-iii-clinical-studies\" target=\"_blank\">completes enrollment </a>ahead of schedule in two Phase 3 clinical trials evaluating KX2-381 (KX-01) for the topical treatment of actinic keratosis (rough scaly patches on the skin from sun damage).</li><li>The primary endpoint of <a href=\"https://clinicaltrials.gov/ct2/show/NCT03285477?spons=athenex&amp;phase=2&amp;rank=2\" target=\"_blank\">both trials</a> is complete response rate. The estimated primary completion dates are both in late June.</li><li><a href=\"https://www.athenex.com/oncology-innovation/src-kinase-inhibitors/\" target=\"_blank\">KX-01</a>&nbsp;inhibits a proto-oncogene called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Proto-oncogene_tyrosine-protein_kinase_Src\" target=\"_blank\">kinase Src</a>, of which elevated levels are associated with cancer progression.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317536-athenex-licenses-lead-candidate-kxminus-01-275m-investors-unmoved-shares-13-percent\" target=\"_blank\">Athenex out-licenses lead candidate KX-01 for up to $275M; investors unmoved, shares down 13%</a> (Dec. 11, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331027\" data-linked=\"Athenex advancing late-stage studies of KX2-391 in actinic keratosis; shares up 1%\" data-tweet=\"$ATNX - Athenex advancing late-stage studies of KX2-391 in actinic keratosis; shares up 1% https://seekingalpha.com/news/3331027-athenex-advancing-late-stage-studies-of-kx2minus-391-in-actinic-keratosis-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3331027-athenex-advancing-late-stage-studies-of-kx2minus-391-in-actinic-keratosis-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331015\" data-ts=\"1518622229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331015-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>+1.8</strong><strong>M </strong>barrels vs. +2.8M consensus, +1.9M last week.</li><li>Gasoline <strong>+3.6</strong><strong>M</strong>&nbsp;barrels vs. +1.2M consensus, +3.4M last week.</li><li>Distillates <strong>-0.5</strong><strong>M</strong>&nbsp;barrels vs. -1.1M consensus, +3.9M last week.</li>     <li>Futures&nbsp;<font color='red'>-0.96%</font>&nbsp;to $58.62.</li>     <li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331015\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3331015-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3331015-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>114&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331014\" data-ts=\"1518622088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABUS\" target=\"_blank\">ABUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331014-arbutus-biopharma-up-3-on-planned-joint-development-of-roivant-sciences-nucleic-acid-delivery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arbutus Biopharma up 3% on planned joint development of Roivant Sciences&#39; nucleic acid delivery platform</a></h4><ul><li>A <a href=\"https://www.sec.gov/Archives/edgar/data/1447028/000110465918009305/a18-6122_1sc13da.htm\" target=\"_blank\">13D filing</a> by Arbutus Biopharma (<a href='https://seekingalpha.com/symbol/ABUS' title='Arbutus Biopharma Corp'>ABUS</a> <font color='green'>+2.7%</font>) discloses a 29.1% stake (~16M shares) owned by privately held London, England-based Roivant Sciences.</li><li>The companies are <a href=\"https://www.sec.gov/Archives/edgar/data/1447028/000110465918009305/a18-6122_1ex7d09.htm\" target=\"_blank\">negotiating </a>a plan to jointly develop Roivant's nucleic acid delivery platform via a new entity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331014\" data-linked=\"Arbutus Biopharma up 3% on planned joint development of Roivant Sciences&#39; nucleic acid delivery platform\" data-tweet=\"$ABUS - Arbutus Biopharma up 3% on planned joint development of Roivant Sciences&#39; nucleic acid delivery platform https://seekingalpha.com/news/3331014-arbutus-biopharma-up-3-on-planned-joint-development-of-roivant-sciences-nucleic-acid-delivery?source=tweet\" data-url=\"https://seekingalpha.com/news/3331014-arbutus-biopharma-up-3-on-planned-joint-development-of-roivant-sciences-nucleic-acid-delivery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330990\" data-ts=\"1518621601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DENN\" target=\"_blank\">DENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330990-on-dennys-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Denny&#39;s Q4 results</a></h4><ul><li>Denny&rsquo;s (<a href='https://seekingalpha.com/symbol/DENN' title='Denny&#39;s Corporation'>DENN</a> <font color='green'>+7.4%</font>) reported Q4 restaurant sales growth of 6% Y/Y and franchise and license revenue growth of 0.5% Y/Y.</li><li>Domestic same-store sales +2.2%; company restaurants +2.1% and domestic franchise restaurants +2.2%.</li><li>Q4 operating margin&nbsp;<font color='red'>declined 140 bps</font>&nbsp;to 30.9%; restaurant operating margin&nbsp;<font color='red'>declined 120 bps</font>, franchise operating margin&nbsp;<font color='green'>improved 10 bps.</font></li><li>They opened 14 new system restaurants including 3 international franchised locations.</li><li>FY2018 guidance: Same-store sales growth of 0-2%; revenue $634-642M; tax rate of 22-24%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330700-dennys-beats-0_02-misses-revenue\" target=\"_blank\">Denny's beats by $0.02, misses on revenue</a> (Feb. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3330990\" data-linked=\"More on Denny&#39;s Q4 results\" data-tweet=\"$DENN - More on Denny&#39;s Q4 results https://seekingalpha.com/news/3330990-on-dennys-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3330990-on-dennys-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331011\" data-ts=\"1518621233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAD\" target=\"_blank\">LAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331011-on-lithia-motors-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Lithia Motors&#39; Q4</a></h4><ul> <li>Lithia Motors (<a href='https://seekingalpha.com/symbol/LAD' title='Lithia Motors, Inc.'>LAD</a> <font color='red'>-4.4%</font>)&nbsp;reports total same-store sales rose 2.6% in <a href=\"https://seekingalpha.com/pr/17074309-lithia-reports-record-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>.</li><li>Same-store sales breakdown:&nbsp;New vehicle retail: +3.2%;&nbsp;Used vehicle retail: +2.3%; Finance and insurance: +8.4%;&nbsp;Service, body and parts: +3.5%.</li><li>Revenue breakdown:&nbsp;New vehicle retail: $1.62B (+21%);&nbsp;Used vehicle retail: $629.34M (+12.4%);&nbsp;Used vehicle wholesale: $71.09M (+2.3%);&nbsp;Finance and insurance: $103.19M (+12.1%);&nbsp;Service, body and parts: $271.59M (+18.9%);&nbsp;Fleet and other: $12.18M (-13.2%).</li><li>Same store F&amp;I per unit +6.7% Y/Y to $1,342.</li><li>Gross margin rate improved 10 bps to 14.7%.</li><li>Adjusted SG&amp;A expense rate -10 bps to 10.1%.</li><li>Adjusted operating margin rate up 20 bps 4%.</li><li>Total retail units sold +15.1% Y/Y to 77,444 units.</li><li><b>FY2018 Guidance</b>: Total revenues: $11B to $11.5B; Adjusted EPS: $10; Tax rate: ~27%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331011\" data-linked=\"More on Lithia Motors&#39; Q4\" data-tweet=\"$LAD - More on Lithia Motors&#39; Q4 https://seekingalpha.com/news/3331011-on-lithia-motors-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331011-on-lithia-motors-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331010\" data-ts=\"1518621211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331010-jd-com-seals-2_5b-financing-for-logistics-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com seals $2.5B financing for logistics unit</a></h4><ul>   <li>JD.com (<a href=\"http://seekingalpha.com/symbol/JD\" target=\"_blank\">JD</a> <font color='green'>+4.1%</font>) says it has definitive deals for financing its JD Logistics unit with a <a href=\"https://seekingalpha.com/pr/17074162-jd-com-announces-financing-agreements-jd-logistics\" target=\"_blank\">round of $2.5B</a>.</li>    <li>Taking part are investors including Hillhouse Capital, Sequoia China, China Merchants Group, Tencent, China Life, China Development Bank Capital FOF, China Structural Reform Fund and ICBC International.</li>    <li>JD will continue to hold about 81.4% of the unit after the transaction.</li>    <li>The deal will allow JD to \"further invest in expanding our lead in the sector in areas like automation, drones and robotics,\" says Chairman/CEO Richard Liu. \"JD Logistics will continue to support both JD.com&rsquo;s e-commerce business and the logistical needs for a wide range of industries for years to come.&rdquo;</li>    <li>It's expected to close in Q1.</li><li>The company reports earnings on March 2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331010\" data-linked=\"JD.com seals $2.5B financing for logistics unit\" data-tweet=\"$JD - JD.com seals $2.5B financing for logistics unit https://seekingalpha.com/news/3331010-jd-com-seals-2_5b-financing-for-logistics-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3331010-jd-com-seals-2_5b-financing-for-logistics-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331009\" data-ts=\"1518621043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABMD\" target=\"_blank\">ABMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331009-fda-oks-expanded-use-for-abiomeds-impella-2_5-and-cp-heart-pumps-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expanded use for Abiomed&#39;s Impella 2.5 and CP heart pumps; shares up 3%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17074455-abiomed-receives-approval-expanded-fda-indication-high-risk-percutaneous-coronary\" target=\"_blank\">approves</a> the use of Abiomed's (<a href='https://seekingalpha.com/symbol/ABMD' title='ABIOMED, Inc.'>ABMD</a> <font color='green'>+2.8%</font>) Impella 2.5 and Impella CP heart pumps for patients with severe coronary artery disease, complex anatomy and extensive comorbidities, with or without depressed ejection fraction, who are undergoing high-risk percutaneous coronary intervention &#40;PCI&#41; procedures.</li><li>Previously, the patient selection criteria required depressed ejection fraction.</li><li>Both devices provide temporary ventricular support during elective or urgent high-risk PCI.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331009\" data-linked=\"FDA OKs expanded use for Abiomed&#39;s Impella 2.5 and CP heart pumps; shares up 3%\" data-tweet=\"$ABMD - FDA OKs expanded use for Abiomed&#39;s Impella 2.5 and CP heart pumps; shares up 3% https://seekingalpha.com/news/3331009-fda-oks-expanded-use-for-abiomeds-impella-2_5-and-cp-heart-pumps-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3331009-fda-oks-expanded-use-for-abiomeds-impella-2_5-and-cp-heart-pumps-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330997\" data-ts=\"1518619489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIS\" target=\"_blank\">GIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330997-jefferies-positive-on-general-mills\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies positive on General Mills</a></h4><ul> <li>Jefferies upgrades General Mills (<a href='https://seekingalpha.com/symbol/GIS' title='General Mills, Inc.'>GIS</a> <font color='red'>-0.2%</font>) to a Buy rating after having the food stock slotted at Hold.</li> <li>The firm's note focuses on the improving organic sales growth trends at General Mills and the attractive valuation at its current trading price.</li> <li>Shares of General Mills are down 7.6% YTD and trade at roughly 17X this year's consensus EPS estimate.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3330997\" data-linked=\"Jefferies positive on General Mills\" data-tweet=\"$GIS - Jefferies positive on General Mills https://seekingalpha.com/news/3330997-jefferies-positive-on-general-mills?source=tweet\" data-url=\"https://seekingalpha.com/news/3330997-jefferies-positive-on-general-mills\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330995\" data-ts=\"1518619235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTO\" target=\"_blank\">CRTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330995-criteo-jumps-24-after-q4-report-is-all-positivity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Criteo jumps 24% after Q4 report is all positivity</a></h4><ul>   <li>Criteo (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a>) has bulled out of the market open, <font color='green'>up 24.4%</font> after its double-barreled <a href=\"https://seekingalpha.com/news/3330888-criteo-s-beats-0_28-beats-revenue\" target=\"_blank\">beat in Q4</a>.</li>    <li>Revenue ex-TAC rose 23% to $277M with broad gains, and net income rose 29% to $52M; adjusted net income was up 47% to $82M.</li>    <li>EBITDA was up 45% to $120M, beating an expected $107.3M driven by broad revenue gains along with continued oeprating leverage and a stronger focus on productivity.</li>    <li>Revenue ex-TAC by region: Americas, $121M (up 22%); EMEA, $100M (up 24%); Asia-Pacific, $55M (up 23%).</li>    <li>For Q1, it's guiding to revenue ex-TAC of $230M-$235M (above consensus for $204.6M), and EBITDA of $60M-$65M (above expectations for $45.6M). For the full year, it's forecasting revenue ex-TAC growth of 3-8% at constant currency, and EBITDA margin of 28-30% of revenue ex-TAC.</li>    <li><a href=\"https://seekingalpha.com/pr/17074301-criteo-reports-record-results-fourth-quarter-fiscal-year-2017\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3330995\" data-linked=\"Criteo jumps 24% after Q4 report is all positivity\" data-tweet=\"$CRTO - Criteo jumps 24% after Q4 report is all positivity https://seekingalpha.com/news/3330995-criteo-jumps-24-after-q4-report-is-all-positivity?source=tweet\" data-url=\"https://seekingalpha.com/news/3330995-criteo-jumps-24-after-q4-report-is-all-positivity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330993\" data-ts=\"1518618760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRC\" target=\"_blank\">NRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330993-on-national-researchs-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on National Research&#39;s Q4</a></h4><ul> <li>National Research Corporation (NRCIB) <a href=\"https://seekingalpha.com/pr/17074117-national-research-corporation-announces-fourth-quarter-year-end-2017-results\" target=\"_blank\">reports</a> net new sales&nbsp;of $6.2M in Q4 and $22.2M for FY2017.</li><li>Total contract value for FY2017 was $125.1M.</li><li>SG&amp;A expense rate grew 230 bps to 25.6%.</li><li>Operating margin rate squeezed 210 bps to 29% for the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330809-national-research-eps-0_15\" target=\"_blank\">National Research EPS of $0.15</a> (Feb. 13)</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3330993\" data-linked=\"More on National Research&#39;s Q4\" data-tweet=\"$NRC - More on National Research&#39;s Q4 https://seekingalpha.com/news/3330993-on-national-researchs-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3330993-on-national-researchs-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330988\" data-ts=\"1518618558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VXRT\" target=\"_blank\">VXRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330988-aviragen-completes-merger-vaxart-executes-1-11-reverse-stock-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aviragen completes merger with Vaxart, executes 1:11 reverse stock split</a></h4><ul><li>Aviragen (AVIR) <a href=\"https://seekingalpha.com/pr/17074143-vaxart-inc-closes-merger-aviragen-therapeutics-inc\" target=\"_blank\">completes its tie-up</a> with Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>). The combined company will do business as Vaxart and will trade under its current symbol. Effective today, shares will reflect a 1:11 reverse split.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3305521-aviragen-merge-vaxart\" target=\"_blank\">Aviragen to merge with Vaxart</a> (Oct. 30, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3330988\" data-linked=\"Aviragen completes merger with Vaxart, executes 1:11 reverse stock split\" data-tweet=\"$VXRT - Aviragen completes merger with Vaxart, executes 1:11 reverse stock split https://seekingalpha.com/news/3330988-aviragen-completes-merger-vaxart-executes-1-11-reverse-stock-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3330988-aviragen-completes-merger-vaxart-executes-1-11-reverse-stock-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330986\" data-ts=\"1518618417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330986-groupon-10-lower-after-q4-profits-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon 10% lower after Q4 profits miss</a></h4><ul>   <li>Groupon (NASDAQ:<a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a>) is <font color='red'>9.6% lower</font> premarket after posting <a href=\"https://seekingalpha.com/news/3330955-groupon-misses-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a> that saw a dip in revenues and profits that missed Street expectations despite record EBITDA.</li>    <li>Direct revenues fell by double digits even as marketing expenses rose.</li>    <li>Net income from continuing operations swung to a gain of $51.1M from a year-ago loss of $39.5M. EBITDA hit a quarterly record of $105.3M, up 31%.</li>    <li>Global units sold fell 6% to 54.6M as the company worked to maximize gross profit (which rose 10% to $386.9M).</li>    <li>Revenue breakout: Third-party and other, $346.6M (up 8.8%); Direct, $526.6M (down 10.2%).</li>    <li>Operating cash flow was $270.6M, and free cash flow was $255.1M.</li>    <li>For 2018, it's guiding to EBITDA of $260M-$270M, light of consensus for $271.7M.</li>    <li><a href=\"http://investor.groupon.com\" target=\"_blank\">Conference call</a> to come at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17074582-groupon-announces-fourth-quarter-fiscal-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3330986\" data-linked=\"Groupon 10% lower after Q4 profits miss\" data-tweet=\"$GRPN - Groupon 10% lower after Q4 profits miss https://seekingalpha.com/news/3330986-groupon-10-lower-after-q4-profits-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3330986-groupon-10-lower-after-q4-profits-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330984\" data-ts=\"1518618147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOSL\" target=\"_blank\">FOSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330984-premarket-gainers-of-9-05-02-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (02/14/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a>&nbsp;<font color='green'>+81%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330974-moonshot-fossil-called\" target=\"_blank\">transition</a> to an e-commerce/wearable tech player.</li><li><a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>&nbsp;<font color='green'>+29%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330940-inspiremd-reports-q4-results\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+28%</font>&nbsp;on stock <a href=\"https://seekingalpha.com/news/3330952-zosano-pharma-34-percent-premarket-ahead-stock-offering\" target=\"_blank\">offering</a>.</li><li><a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='green'>+28%</font>.</li><li><a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a> <font color='green'>+28%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330888-criteo-s-beats-0_28-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330757-chipotle-pops-nabbing-taco-bell-ceo\" target=\"_blank\">hiring</a>&nbsp;CEO.</li><li><a href='https://seekingalpha.com/symbol/WIX' title='Wix.com'>WIX</a> <font color='green'>+10%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330814-wix-com-eps-line-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+9%</font>&nbsp;on&nbsp;fuel cell truck <a href=\"https://seekingalpha.com/news/3330910-ballard-plus-13_8-percent-fuel-cell-truck-deployment\" target=\"_blank\">deployment</a>.</li><li><a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+9%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330724-twilio-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/ACTG' title='Acacia Research Corporation'>ACTG</a> <font color='green'>+8%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330693-acacia-research-eps-2_04\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+8%</font>&nbsp;on bitcoin <a href=\"https://seekingalpha.com/news/3330909-bitcoin-continues-rally-eyes-10k\" target=\"_blank\">rally</a>.</li><li><a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='green'>+8%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3330966-universal-display-samsung-announce-long-term-oled-agreements\" target=\"_blank\">extended supply agreements</a>&nbsp;with Samsung (<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>).</li><li><a href='https://seekingalpha.com/symbol/CALX' title='Calix, Inc.'>CALX</a> <font color='green'>+6%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330675-calix-misses-0_02-misses-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color='green'>+6%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3330732-baidu-beats-0_19-misses-revenue\" target=\"_blank\">result</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3330984\" data-linked=\"Premarket Gainers as of 9:05 am (02/14/2018)\" data-tweet=\"$FOSL $FOSL $NSPR - Premarket Gainers as of 9:05 am (02/14/2018) https://seekingalpha.com/news/3330984-premarket-gainers-of-9-05-02-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3330984-premarket-gainers-of-9-05-02-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330981\" data-ts=\"1518618063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALKS\" target=\"_blank\">ALKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330981-alkermes-q4-revenues-up-29-updates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alkermes Q4 revenues up 29%; updates guidance</a></h4><ul><li>Alkermes (<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a>) <a href=\"https://seekingalpha.com/pr/17074319-alkermes-plc-reports-financial-results-year-ended-dec-31-2017-provides-financial-expectations\" target=\"_blank\">Q4 results</a>: Revenues: $275.4M (+29.0%); Operating Income: $5.8M; Net Loss: ($9.8M) (+53.6%); Loss Per Share: ($0.06) (+57.1%); Non-GAAP EPS: $0.31 (+106.7%); Quick Assets: $590.7M (-4.6%).</li><li><strong>2018 Guidance</strong>: GAAP EPS: ($1.71); Non-GAAP EPS: ($0.13).</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3330981\" data-linked=\"Alkermes Q4 revenues up 29%; updates guidance\" data-tweet=\"$ALKS - Alkermes Q4 revenues up 29%; updates guidance https://seekingalpha.com/news/3330981-alkermes-q4-revenues-up-29-updates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3330981-alkermes-q4-revenues-up-29-updates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330982\" data-ts=\"1518618017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARX\" target=\"_blank\">RARX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330982-ra-pharma-prices-stock-offering-6-shares-down-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ra Pharma prices stock offering at $6, shares down 13% premarket</a></h4><ul><li>Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a>) <a href=\"https://seekingalpha.com/pr/17074757-ra-pharmaceuticals-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 8.4M shares of common stock at $6 per share. Underwriters over-allotment is an additional 1.26M shares. Closing date is February 16.</li><li>Yesterday's close was $6.54. Shares are down&nbsp;<font color='red'>13%&nbsp;</font>premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3330982\" data-linked=\"Ra Pharma prices stock offering at $6, shares down 13% premarket\" data-tweet=\"$RARX - Ra Pharma prices stock offering at $6, shares down 13% premarket https://seekingalpha.com/news/3330982-ra-pharma-prices-stock-offering-6-shares-down-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3330982-ra-pharma-prices-stock-offering-6-shares-down-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330985\" data-ts=\"1518617993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330985-gold-fieldsminus-7-south-africa-production-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields -7% as South Africa production falls</a></h4><ul>     <li>Gold Fields (NYSE:<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>) <font color='red'>-7.3%</font> premarket after reporting <a href=\"https://seekingalpha.com/news/3330816-gold-fields-reports-fy-results\" target=\"_blank\">FY 2017 results</a>, with profit falling 4% Y/Y and production from its South Deep mine in South Africa coming in <a href=\"https://www.nasdaq.com/article/gold-fields-profit-falls-on-lower-south-africa-output-20180214-00040\" target=\"_blank\">below guidance</a>.</li>     <li>Headline EPS from continuing operations fell to $0.24 for 2017 from $0.25 in 2016 but were in line with market expectations.</li>     <li>GFI says it incurred a 3.5B rand ($293.5M) goodwill impairment due to the slow start of the rebase plan over the year at South Deep and a reduction in the gold price.</li>     <li>Production at South Deep for the year came in 11% below original guidance at 281K oz. vs. 290K oz. in 2016, \"impacted by two fatalities and three falls of ground in the high grade corridors.\"</li>     <li>GFI also declares a final dividend of 0.50 rand/share ($0.04), taking the total dividend for the year to 0.90 rand/share ($0.08).</li></ul><div class=\"tiny-share-widget\" data-id=\"3330985\" data-linked=\"Gold Fields -7% as South Africa production falls\" data-tweet=\"$GFI - Gold Fields -7% as South Africa production falls https://seekingalpha.com/news/3330985-gold-fieldsminus-7-south-africa-production-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/3330985-gold-fieldsminus-7-south-africa-production-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330980\" data-ts=\"1518617985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330980-teslas-plans-to-manufacture-in-china-stuck-in-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla&#39;s plans to manufacture in China stuck in neutral</a></h4><ul> <li>There could be trouble for Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) in China, according to a <a href=\"https://www.bloomberg.com/news/articles/2018-02-14/tesla-s-china-dream-threatened-by-standoff-over-shanghai-factory\" target=\"_blank\">report</a> from Bloomberg.</li> <li>Sources indicate that the automaker hasn't reached an agreement yet with the Shanghai government on manufacturing cars locally without a JV partner.</li> <li>Tesla is trying to work out the exception with China's Ministry of Commerce, National Development and Reform Commission and the Shanghai Economy and Information Commission.</li> <li>Bloomberg notes that while an agreement between Tesla and China authorities can still be hashed out in the future, some market opportinties are slipping away.</li> <li>Shares of Tesla are&nbsp;<font color='red'>down 0.88%</font>&nbsp;premarket to $320.80, roughly in line with broad market averages.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3330980\" data-linked=\"Tesla&#39;s plans to manufacture in China stuck in neutral\" data-tweet=\"$TSLA - Tesla&#39;s plans to manufacture in China stuck in neutral https://seekingalpha.com/news/3330980-teslas-plans-to-manufacture-in-china-stuck-in-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3330980-teslas-plans-to-manufacture-in-china-stuck-in-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330979\" data-ts=\"1518617900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330979-premarket-losers-of-9-05-2-14-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (2/14/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a>&nbsp;<font color='red'>-49%</font>&nbsp;on eravacycline&nbsp;<a href=\"https://seekingalpha.com/news/3330776-tetraphase-pharmas-eravacycline-fails-match-ertapenem-late-stage-cuti-study-shares-57-percent\" target=\"_blank\">failing</a> to match ertapenem in late-stage cUTI study.</li><li><a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-29%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17074595-avinger-announces-pricing-18-million-underwritten-public-offering\" target=\"_blank\">pricing</a> $18M underwritten public offering.</li><li><a href='https://seekingalpha.com/symbol/PIRS' title='Pieris Pharmaceuticals, Inc.'>PIRS</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330911-pieris-pharma-prices-stock-offering-8_00-shares-14-percent-premarket\" target=\"_blank\">pricing</a>&nbsp;stock offering at $8.00</li><li><a href='https://seekingalpha.com/symbol/NMM' title='Navios Maritime Partners L.P.'>NMM</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330803-navios-maritime-partners-launch-35m-offering\" target=\"_blank\">announcing</a> a&nbsp;public offering&nbsp;of $35M of common units.</li><li><a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330806-ra-pharmaceuticals-minus-2_1-percent-plans-50m-offering\" target=\"_blank\">announcing</a> proposed public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330955-groupon-misses-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>&nbsp;<font color='red'>-7%&nbsp;</font>on&nbsp;<a href=\"https://seekingalpha.com/news/3330816-gold-fields-reports-fy-results\" target=\"_blank\">fiscal earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330760-omega-healthcare-investors-ffo-line-misses-rental-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3330850-bunge-misses-0_70-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3330979\" data-linked=\"Premarket Losers as of 9:05 am (2/14/2018)\" data-tweet=\"$TTPH $TTPH $AVGR - Premarket Losers as of 9:05 am (2/14/2018) https://seekingalpha.com/news/3330979-premarket-losers-of-9-05-2-14-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3330979-premarket-losers-of-9-05-2-14-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330966\" data-ts=\"1518616428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330966-universal-display-samsung-announce-long-term-oled-agreements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display, Samsung announce long-term OLED agreements</a></h4><ul>     <li>Universal Display (NASDAQ:<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a>)&nbsp;<font color='green'>+8.1%</font> premarket following news that it <a href=\"https://seekingalpha.com/pr/17074259-samsung-display-universal-display-corporation-enter-long-term-oled-agreements\" target=\"_blank\">extended its supply agreements</a> with Samsung (<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) through year-end 2022.</li>     <li>OLED says the agreements affirm that the company will continue to supply its UniversalPHOLED phosphorescent OLED materials and technology to Samsung Display for use in its OLED displays.</li>     <li>Financial terms of the agreements are not disclosed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3330966\" data-linked=\"Universal Display, Samsung announce long-term OLED agreements\" data-tweet=\"$OLED $OLED $SSNLF - Universal Display, Samsung announce long-term OLED agreements https://seekingalpha.com/news/3330966-universal-display-samsung-announce-long-term-oled-agreements?source=tweet\" data-url=\"https://seekingalpha.com/news/3330966-universal-display-samsung-announce-long-term-oled-agreements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330963\" data-ts=\"1518615714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330963-teck-resourcesminus-4-after-disappointing-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources -4% after disappointing Q4 results</a></h4><ul>     <li>Teck Resources (NYSE:<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a>) <font color='red'>-4.2%</font> premarket after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3330827-teck-resources-misses-c-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a> and a 10% Y/Y drop in revenues,</li>     <li>Teck's adjusted Q4 profit fell to C$700M, or C$1.21/share, from C$930M, or C$1.61/share, in the year-ago period, due mostly to lower prices and sales volumes in its steelmaking coal business.</li>     <li>Q4 adjusted EBITDA was $1.5B compared with $1.9B in the year-ago quarter, but adjusted EBITDA for FY 2017 was $5.7B vs. $3.5B for 2016; Q4 cash flow from operations of $1.5B was the same as a year ago but came in at a record $5.1B for the full year vs. $3.1B in 2016.</li>     <li>Teck says Q4 sales of steelmaking coal fell 8% Y/Y to 6.4M metric tons at an average realized price of $170/ton, slightly below its December forecast for 6.5M metric tons of production at an average price of $165-$170/ton.</li>     <li>For FY 2018, Teck forecasts steelmaking coal production 26M-27M metric tons vs. 26.6M tons in 2017, copper production of 270K-285K metric tons vs. 287.3K tons last year, and zinc concentrate production of  645K-670K metric tons vs. 658.7K tons produced in 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3330963\" data-linked=\"Teck Resources -4% after disappointing Q4 results\" data-tweet=\"$TECK - Teck Resources -4% after disappointing Q4 results https://seekingalpha.com/news/3330963-teck-resourcesminus-4-after-disappointing-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3330963-teck-resourcesminus-4-after-disappointing-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330961\" data-ts=\"1518615609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVDL\" target=\"_blank\">AVDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330961-avadel-pharma-prices-convertible-debt-offering-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avadel Pharma prices convertible debt offering; shares down 10% premarket</a></h4><ul><li>Thinly traded micro cap Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) slips&nbsp;<font color='red'>10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17074529-avadel-pharmaceuticals-announces-pricing-125_0-million-4_50-percent-exchangeable-senior-notes\" target=\"_blank\">$125M offering</a> of 4.50% exchangeable senior notes due 2023 to institutional investors. Initial buyers will have the option to purchase up to an additional $18.75M of the notes. Net proceeds will be ~$119.6M ($137.7M if all additional notes are purchased).</li><li>The initial conversion rate will be 92.6956 ADSs per $1,000 principal amount of the notes (~$10.79/ADS).</li><li>Concurrently, the company intends to purchase ~$18M of ADSs via privately negotiated transactions with the convertible debt investors (either directly or through a representative).</li><li>Yesterday's close was $8.99.</li></ul><div class=\"tiny-share-widget\" data-id=\"3330961\" data-linked=\"Avadel Pharma prices convertible debt offering; shares down 10% premarket\" data-tweet=\"$AVDL - Avadel Pharma prices convertible debt offering; shares down 10% premarket https://seekingalpha.com/news/3330961-avadel-pharma-prices-convertible-debt-offering-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3330961-avadel-pharma-prices-convertible-debt-offering-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}